The study has been carried out by researchers from the Institute for Bioengineering of Catalonia (IBEC) in collaboration with the Center for Genomic Regulation (CRG). The comprehensive mutation map, which is the first of its kind, has the potential to help clinical geneticists predict whether the mutations found in amyloid beta can make an individual more prone to developing Alzheimer’s disease later in life.
Similar maps have been built for the BRCA1 gene and breast cancer in the past and it is exciting we can replicate this for Alzheimer’s disease.
Benedetta Bolognesi, junior group leader at IBEC
You can read the full articles here:
- El Correo Gallego (PDF)
- El Correo Gallego (online)
- Gaceta Médica (PDF)
- Gaceta Médica (online)
- CEAFA
- News Medical Life Sciences
